159 related articles for article (PubMed ID: 21427555)
41. Personalized medicine in metastatic colorectal cancer treated with anti-epidermal growth factor receptor agents: a future opportunity?
Tejpar S; Piessevaux H
Asia Pac J Clin Oncol; 2014 Mar; 10 Suppl 1():2-10. PubMed ID: 24512508
[TBL] [Abstract][Full Text] [Related]
42. Prior exposure to chemotherapy: a marker of sensitivity and selection for antiangiogenic therapy in breast cancer?
Xynos ID; Tanna N; Patten DK; Palmieri C
Expert Rev Anticancer Ther; 2014 Feb; 14(2):163-72. PubMed ID: 24308686
[TBL] [Abstract][Full Text] [Related]
43. Biomarker-based selection of therapy for colorectal cancer.
Ross JS
Biomark Med; 2011 Jun; 5(3):319-32. PubMed ID: 21657841
[TBL] [Abstract][Full Text] [Related]
44. Antiangiogenic therapy in colorectal cancer: where are we 5 years later?
Jenab-Wolcott J; Giantonio BJ
Clin Colorectal Cancer; 2010 Jun; 9 Suppl 1():S7-15. PubMed ID: 20630853
[TBL] [Abstract][Full Text] [Related]
45. Pharmacogenomic contribution to drug response.
Watson RG; McLeod HL
Cancer J; 2011; 17(2):80-8. PubMed ID: 21427551
[TBL] [Abstract][Full Text] [Related]
46. Novel drug discovery opportunities for colorectal cancer.
Curtin JC
Expert Opin Drug Discov; 2013 Sep; 8(9):1153-64. PubMed ID: 23768167
[TBL] [Abstract][Full Text] [Related]
47. [Omics docking and molecular classification in colorectal cancer].
Peng Y; Shen S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 35(11):1201-6. PubMed ID: 21131745
[TBL] [Abstract][Full Text] [Related]
48. Translation initiation in colorectal cancer.
Parsyan A; Hernández G; Meterissian S
Cancer Metastasis Rev; 2012 Jun; 31(1-2):387-95. PubMed ID: 22418835
[TBL] [Abstract][Full Text] [Related]
49. Pharmacogenetic aspects in treatment of colorectal cancer--an update.
Stoehlmacher J; Goekkurt E; Lenz HJ
Pharmacogenomics; 2003 Nov; 4(6):767-77. PubMed ID: 14596640
[TBL] [Abstract][Full Text] [Related]
50. Integrating biomarkers into clinical decision making for colorectal cancer.
Wilson PM; Lenz HJ
Clin Colorectal Cancer; 2010 Jun; 9 Suppl 1():S16-27. PubMed ID: 20630847
[TBL] [Abstract][Full Text] [Related]
51. Molecular markers for colon diagnosis, prognosis and targeted therapy.
Herzig DO; Tsikitis VL
J Surg Oncol; 2015 Jan; 111(1):96-102. PubMed ID: 25297801
[TBL] [Abstract][Full Text] [Related]
52. Translational research of new developments in targeted therapy of colorectal cancer.
Yang L; Atakhanova N; Arellano MTC; Mohamed MY; Hani T; Fahdil AA; Castillo-Acobo RY; Juyal A; Hussein AK; Amin AH; Pecho RDC; Akhavan-Sigari R
Pathol Res Pract; 2023 Dec; 252():154888. PubMed ID: 37948996
[TBL] [Abstract][Full Text] [Related]
53. The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges.
Rogers JE; Dasari A; Eng C
Oncologist; 2016 May; 21(5):563-70. PubMed ID: 27000464
[TBL] [Abstract][Full Text] [Related]
54. Molecular pathology of colorectal cancer.
Bosman F; Yan P
Pol J Pathol; 2014 Dec; 65(4):257-66. PubMed ID: 25693079
[TBL] [Abstract][Full Text] [Related]
55. Circulating endothelial cells and circulating endothelial cell progenitors as surrogate markers for determining response to antiangiogenic agents.
Gupta M
Clin Colorectal Cancer; 2007 Jan; 6(5):337-8. PubMed ID: 17311697
[No Abstract] [Full Text] [Related]
56. Translating the molecular analysis of cancer biology into therapeutic concepts.
Mader RM; Brodowicz T; Zielinski CC
Cancer Biomark; 2014; 14(2-3):87-91. PubMed ID: 24878809
[TBL] [Abstract][Full Text] [Related]
57. Targeted therapy of cancer: new roles for pathologists in colorectal cancer.
Hamilton SR
Mod Pathol; 2008 May; 21 Suppl 2():S23-30. PubMed ID: 18437170
[TBL] [Abstract][Full Text] [Related]
58. Natural products for treating colorectal cancer: A mechanistic review.
Huang XM; Yang ZJ; Xie Q; Zhang ZK; Zhang H; Ma JY
Biomed Pharmacother; 2019 Sep; 117():109142. PubMed ID: 31238258
[TBL] [Abstract][Full Text] [Related]
59. Molecular testing to optimize therapeutic decision making in advanced colorectal cancer.
Semrad TJ; Kim EJ
J Gastrointest Oncol; 2016 Apr; 7(Suppl 1):S11-20. PubMed ID: 27034809
[TBL] [Abstract][Full Text] [Related]
60. Update on systemic therapy for colorectal cancer: biologics take sides.
Gbolahan O; O'Neil B
Transl Gastroenterol Hepatol; 2019; 4():9. PubMed ID: 30976712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
